Hui Wang’s story: Cross-cultural coordination for clinical trials

The missing element is coordination


The first Chinese company granted permission by the FDA to initiate a clinical trial in the USA found itself amidst intense competition, with several other companies vying to bring the same drug product to market. While the professionals in China possessed extensive knowledge, conveying the intricate technical details posed a challenge, necessitating fluency in three languages: English, Mandarin, and Science.

Enter Hui Wang, whose invaluable experience in the pharmaceutical sector proved pivotal to this challenge. Leveraging her expertise, she adeptly identified and translated all crucial process information to Thermo Fisher Scientific's team in the USA. Typically, such a project would take months, but through Hui's unwavering dedication to coordination, we achieved a seamless technology transfer in a mere two weeks.